Finance

Beta
Lists
XFOR:NASDAQ
X4 Pharmaceuticals Inc
$4.02
+0.75%
(+0.030) 1D
$4.04
+0.50% (+0.020)
After hours
Closed: Jun 26, 4:00:01 PM GMT-4  ·   USD
All symbols
SymbolPriceChange% Change
Generating top insights for XFOR...
Open
$3.98
High
$4.24
Low
$3.98
Mkt. cap
379.17M
Avg. vol.
425.91K
Volume
10.48M
52-wk high
$4.83
52-wk low
$1.35
EPS
-$4.58
Beta
0.34
Shares outstanding
94.32M
No. of employees
45
Open
$3.98
High
$4.24
Low
$3.98
Mkt. cap
379.17M
Avg. vol.
425.91K
Volume
10.48M
52-wk high
$4.83
52-wk low
$1.35
EPS
-$4.58
Beta
0.34
Shares outstanding
94.32M
No. of employees
45
News stories
From sources across the web
About X4 Pharmaceuticals Inc
CEO-
Employees45
FoundedMar 13, 2019
HeadquartersBoston, Massachusetts, United States
SectorBiotechnology
Websitex4pharma.com
Analyst ratings
Based on 2 analysts giving stock ratings to XFOR in the past 3 months
Buy
Buy
2
Hold
0
Sell
0
12-month forecast
Based on 2 Wall Street analysts offering 12 month price targets for XFOR in the last 3 months.
Highest
Current $4.02
$12.00 (+198.51%)
Average
$12.00 (+198.51%)
Lowest
$12.00 (+198.51%)
Analyst
Recommendation
Action
Price target
Projected
Date
Thomas Smith
Leerink Partners
Buy
Initiated
$12.00
+198.5%
06/02/2026
Michael Schmidt
Guggenheim
Buy
Maintained
$12.00
+198.5%
05/06/2026
James Condulis
Stifel Nicolaus
Buy
Initiated
$10.00
+148.8%
12/05/2025
Kristen Kluska
Cantor Fitzgerald
Buy
Maintained
$14.00
+248.3%
11/21/2025
Previous reportsAll values in USD
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in USD
Jun 2025
Sep 2025
Dec 2025
Mar 2026
Revenue
1.97M
1.76M
2.57M
2.71M
Cost of goods sold
326.00K
351.00K
364.00K
598.00K
Cost of revenue
326.00K
351.00K
364.00K
598.00K
Research and development expenses
18.35M
15.84M
18.72M
15.45M
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
9.53M
8.19M
7.38M
6.93M
Operating expense
27.88M
24.02M
26.10M
22.38M
Total operating expenses
28.20M
24.37M
26.47M
22.98M
Operating income
-26.23M
-22.61M
-23.90M
-20.27M
Other non operating income
2.10M
-980.00K
-25.00K
94.00K
EBT including unusual items
-25.70M
-29.84M
-23.92M
-20.24M
EBT excluding unusual items
-25.70M
-24.94M
-24.12M
-20.20M
Income tax expense
37.00K
-30.00K
-
-
Effective tax rate
-0.14%
0.10%
-
-
Other operating expenses
-
-
-
-
Net income
-25.74M
-29.82M
-23.92M
-20.24M
Net profit margin
-1,304.66%
-1,689.24%
-931.66%
-747.45%
Earnings per share
-3.47
-0.69
-0.22
-0.16
Interest and investment income
665.00K
901.00K
1.98M
2.10M
Interest expense
-2.23M
-2.26M
-2.19M
-2.13M
Net interest expenses
-1.57M
-1.36M
-201.00K
-29.00K
Depreciation and amortization charges
-
-
-
-
EBITDA
-25.88M
-22.39M
-23.68M
-20.05M
Gain or loss from assets sale
-
-
-
-
Insider transactions
Insider transactions data is drawn from third-party sources. Learn more
Insider
Position
Type
Date
Shares
Amount
Page 1
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer

Research

What's on your mind?
Give me an overview of XFOR
Explore what’s possible
Deep Search
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer